EUVIMEDEUVIMED entdecken
Open Access

Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone

Min S Lee, Deborah I Bunin, Anna M Furimsky, Donna Nguyen, Toufan Parman, Kyuri Kim, Linda Rausch, Ming-Teh Lin, Pranab Gupta, Jill E Brown, Jeffrey M Kroopnick, Diana L Blithe

Biology of Reproduction · 2023

DOI: 10.1093/biolre/ioad111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Reproduction, 2023. Verfasst von Min S Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bet…. Hauptthemen laut MEDLINE: Nandrolone, Contraceptive Agents, Male, Prodrugs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male contraceptive development has included use of testosterone (T) with or without a progestin or the use of a single molecule such as progestogenic androgens (PA) for suppression of testicular T production. Expanding upon the vast amount of data accumulated from nortestosterone (NT), NT analogs, and their prodrugs, a new series of PA, the C7 methyl, and ethyl α-substituted T analogs 7α-Methyltestosterone (7α-MT) and 7α-Ethyltestosterone (7α-ET), respectively, were hypothesized and designed to have superior androgenic and progestogenic activities when compared with parent T. Results from androgen receptor and progesterone receptor competitive binding and transcriptional activation assays showed favorable activities for these T analogs. Additionally, 7α-MT and 7α-ET were shown to be active substrates for aromatase in vitro, mitigating a potential negative impact on bone mineral density with long-term use. In conjunction with this observation, the diminished metabolism of these T analogs by 5α-reductase may reduce potential concerns for prostatic growth. In the Hershberger in vivo rat bioassay, 7α-MT and 7α-ET showed superior androgenic and anabolic activities as compared with T. These C7 α-substituted T analogs also showed clear progestogenic activity in the McPhail bioassay which evaluated endometrial glandular arborization in a rabbit model. The discovery of aromatizable molecules with reduced metabolism by 5α-reductase that have androgenic, anabolic, and progestogenic properties indicates that the core and/or prodrugs of 7α-MT and 7α-ET are promising molecules for further development as male contraceptive PAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NandroloneContraceptive Agents, MaleProdrugsMaleRatsRabbitsAnimalsHumansAndrogensTestosteroneProgestinsMethyltestosteroneContraception

Stichwörter der Autor:innen

male contraceptionmetabolismprogestogenic androgentestosterone analogs

Substanzen

AndrogensTestosteroneProgestinsNandroloneMethyltestosteroneContraceptive Agents, MaleProdrugs

Autor:innen und Institutionen

  • Contraceptive Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD, USA.
  • Biosciences Division, SRI International, Menlo Park, CA, USA.
  • Sangamo Therapeutics, Brisbane, CA, USA.
  • Jazz Pharmaceuticals, Palo Alto, CA, USA.
  • Piramal Pharma Solutions, Riverview, MI, USA.
  • Department of Gynecologic Surgery & Obstetrics, Uniformed Services University, Bethesda, MD, USA.

Förderung

  • NICHD NIH HHS
  • HHS
  • NIH HHS
  • National Institutes of Child Health and Human Development
  • National Institutes of Health
  • Department of Health and Human Services
  • SRI International
  • Piramal Pharma Solutions

Zitieren

APA

Lee, M. S., Bunin, D. I., Furimsky, A. M., Nguyen, D., Parman, T., Kim, K., Rausch, L., Lin, M. T., Gupta, P., Brown, J. E., Kroopnick, J. M., & Blithe, D. L. (2023). Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone. Biology of Reproduction. https://doi.org/10.1093/biolre/ioad111

Vancouver

Lee MS, Bunin DI, Furimsky AM, Nguyen D, Parman T, Kim K, et al. Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone. Biology of Reproduction. 2023. doi:10.1093/biolre/ioad111

BibTeX
@article{Lee2023,
  author = {Lee, Min S and Bunin, Deborah I and Furimsky, Anna M and Nguyen, Donna and Parman, Toufan and Kim, Kyuri and Rausch, Linda and Lin, Ming-Teh and Gupta, Pranab and Brown, Jill E and Kroopnick, Jeffrey M and Blithe, Diana L},
  title = {Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone},
  journal = {Biology of Reproduction},
  year = {2023},
  doi = {10.1093/biolre/ioad111}
}
Kostenlos starten →